Pillstats
OTC · Solution/ Drops · Ophthalmic

Olopatadine

Olopatadine Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCR01AC08
RxCUI (US)135391
US makers2 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.357$0.714$1.07$1.43Dec 2025Apr 2026Jul 2026
$1.234
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

19K39K58K77K2025 Q12025 Q22025 Q32025 Q42026 Q1
55K
Rx · 2026 Q1
299K
Units dispensed
+10%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
A-S Medication Solutionsunknown1SUPPLYING
Somerset Therapeutics, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.